Paul Thomen

Wednesday, 24 April 2013

Point of Care Coagulation Testing Market Analysis 2013 in US, Germany, Spain

This new 450-page report from Venture Planning Group contains 53 tables, and provides a comprehensive analysis of the POC coagulation testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market.


The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
- Five-year test volume and reagent sales forecasts for coagulation procedures by market segment:
- Physician Offices/Group Practices
- Emergency Rooms
- Operating/Recovery Suites
- Cancer Clinics
- Ambulatory Care Centers
- Surgery Centers
- Nursing Homes
- Birth Centers

Sales and Market Share Analysis
- Sales and market shares of major coagulation reagent and instrument suppliers.

Current and Emerging Products
- Analysis of coagulation procedures performed in POC testing locations.
- Review of leading coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.

Technology Review
- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.

Competitive Assessments
- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations
- Specific opportunities for new coagulation instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.


This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group’s proprietary data files.

Table of Content

Executive Summary
Rationale for Testing Decentralization
1. Overview
2. Regulatory Trends
3. Economic Trends
4. Demographic Trends
5. Technological Trends
6. Social Trends
7. Quality of Care
8. Defensive Medicine
9. Quality Control Issues
Worldwide Market and Technology Overview
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Factor VIII
8. Fibrin Degradation Products
9. Fibrinogen
10. Heparin
11. Proteins C and S
12. Prothrombin Time (PT)
13. Thrombin Time
Instrumentation: Coagulation Analyzers Manufactured by:
Behnk Elektronik
Cardiovascular Diagnostics
Diagnostica Stago
Helena Laboratories
Instrumentation Laboratory
ITC Hemochron
Teco Medical Instruments
Trinity Biotech
Current and Emerging Technologies
1. Monoclonal Antibodies
2. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
A. Market Overview
1. Business Environment
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
A. Market Overview
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements,
Installed Base, Consumables Sales and Market Shares
A. Business Environment
B. Market Structure
C. Market Summary
D. Test Volume and Sales Forecasts
E. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares
Major Product Development Opportunities
A. Routine and Special Chemistry
B. Microbiology/Infectious Diseases
C. Hematology and Flow Cytometry
D. Coagulation
Design Criteria for Decentralized Testing Products
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
Company Profile
ADI/America Diagnostica
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago/Trinity Biotech
Eiken Chemical
EKF Diagnostics
Helena Laboratories
Instrumentation Laboratory
International Technidyne/Nexus DX
Kyowa Medex
Life Technologies

No comments:

Post a Comment

Note: only a member of this blog may post a comment.